| 1 |
12694666 | Phase II study of CGP 69846A (ISIS 5132) in recurrent epithelial ovarian cancer: an NCIC clinical trials group study (NCIC IND.116). | 2003 Apr |
1 |
| 2 |
12917261 | Protein kinase Cbeta1, a major regulator of TCR-CD28-activated signal transduction leading to IL-2 gene transcription and secretion. | 2003 Sep |
1 |
| 3 |
15000822 | The reduction of Raf-1 protein by phosphorothioate ODNs and siRNAs targeted to the same two mRNA sequences. | 2003 |
1 |
| 4 |
12022686 | In vivo pro-apoptotic and antitumor efficacy of a c-Raf antisense phosphorothioate oligonucleotide: relationship to tumor size. | 2002 Feb |
2 |
| 5 |
10815879 | A phase I trial of c-Raf kinase antisense oligonucleotide ISIS 5132 administered as a continuous intravenous infusion in patients with advanced cancer. | 2000 May |
1 |
| 6 |
11249625 | Development of antisense oligodeoxynucleotides for transplantation. | 2000 Jun |
1 |
| 7 |
10097067 | A cytosine analog that confers enhanced potency to antisense oligonucleotides. | 1999 Mar 30 |
1 |
| 8 |
9072302 | Inhibition of Raf-1 protein kinase by antisense phosphorothioate oligodeoxyribonucleotide is associated with sensitization of human laryngeal squamous carcinoma cells to gamma radiation. | 1997 Jan-Feb |
1 |
| 9 |
8640558 | Antitumor activity of a phosphorothioate antisense oligodeoxynucleotide targeted against C-raf kinase. | 1996 Jun |
4 |
| 10 |
8978841 | 2'-O-aminopropyl ribonucleotides: a zwitterionic modification that enhances the exonuclease resistance and biological activity of antisense oligonucleotides. | 1996 Dec 20 |
1 |
| 11 |
8986837 | Sequence-specific antitumor activity of a phosphorothioate oligodeoxyribonucleotide targeted to human C-raf kinase supports an antisense mechanism of action in vivo. | 1996 Dec 24 |
1 |